These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36853831)

  • 21. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.
    McLane LM; Abdel-Hakeem MS; Wherry EJ
    Annu Rev Immunol; 2019 Apr; 37():457-495. PubMed ID: 30676822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential mechanisms of cancer stem-like progenitor T-cell bio-behaviours.
    Ni L
    Clin Transl Med; 2024 Aug; 14(8):e1817. PubMed ID: 39169517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR
    McClory SE; Bardhan O; Rome KS; Giles JR; Baxter AE; Xu L; Gimotty PA; Faryabi RB; Wherry EJ; Pear WS; Jordan MS
    Cell Rep; 2023 Aug; 42(8):112905. PubMed ID: 37527035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
    Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
    Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies.
    Wei SC; Anang NAS; Sharma R; Andrews MC; Reuben A; Levine JH; Cogdill AP; Mancuso JJ; Wargo JA; Pe'er D; Allison JP
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22699-22709. PubMed ID: 31636208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
    Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
    Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
    Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rgs16 promotes antitumor CD8
    Weisshaar N; Wu J; Ming Y; Madi A; Hotz-Wagenblatt A; Ma S; Mieg A; Hering M; Zettl F; Mohr K; Schlimbach T; Ten Bosch N; Hertel F; Müller L; Byren H; Wang M; Borgers H; Munz M; Schmitt L; van der Hoeven F; Kloz U; Carretero R; Schleußner N; Jackstadt RF; Hofmann I; Cui G
    Sci Immunol; 2022 May; 7(71):eabh1873. PubMed ID: 35622904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma.
    Chang C; Pei Y; Zhang C; Zhang W; Qin Y; Shi S
    Cancer Immunol Immunother; 2023 Nov; 72(11):3727-3738. PubMed ID: 37665374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Mass Cytometry to Profile Human T Cell Exhaustion.
    Winkler F; Bengsch B
    Front Immunol; 2019; 10():3039. PubMed ID: 32038613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
    Wan C; Keany MP; Dong H; Al-Alem LF; Pandya UM; Lazo S; Boehnke K; Lynch KN; Xu R; Zarrella DT; Gu S; Cejas P; Lim K; Long HW; Elias KM; Horowitz NS; Feltmate CM; Muto MG; Worley MJ; Berkowitz RS; Matulonis UA; Nucci MR; Crum CP; Rueda BR; Brown M; Liu XS; Hill SJ
    Cancer Res; 2021 Jan; 81(1):158-173. PubMed ID: 33158814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade.
    Liu Y; Debo B; Li M; Shi Z; Sheng W; Shi Y
    Nat Commun; 2021 Nov; 12(1):6831. PubMed ID: 34819502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
    Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC.
    Shi J; Li G; Liu L; Yuan X; Wang Y; Gong M; Li C; Ge X; Lu S
    Front Immunol; 2023; 14():1166052. PubMed ID: 37077914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Id2 epigenetically controls CD8
    Li Y; Han M; Wei H; Huang W; Chen Z; Zhang T; Qian M; Jing L; Nan G; Sun X; Dai S; Wang K; Jiang J; Zhu P; Chen L
    Cell Mol Immunol; 2024 Mar; 21(3):292-308. PubMed ID: 38287103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of exhausted T cells in the tumor microenvironment is linked to patient survival following resection in hepatocellular carcinoma.
    Liu F; Liu W; Sanin DE; Jia G; Tian M; Wang H; Zhu B; Lu Y; Qiao T; Wang X; Shi Y; Wu D
    Oncoimmunology; 2020; 9(1):1746573. PubMed ID: 32426177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections.
    Domenjo-Vila E; Casella V; Iwabuchi R; Fossum E; Pedragosa M; Castellví Q; Cebollada Rica P; Kaisho T; Terahara K; Bocharov G; Argilaguet J; Meyerhans A
    Cell Rep; 2023 Feb; 42(2):112123. PubMed ID: 36795562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR-independent CD137 (4-1BB) signaling promotes CD8
    Pichler AC; Carrié N; Cuisinier M; Ghazali S; Voisin A; Axisa PP; Tosolini M; Mazzotti C; Golec DP; Maheo S; do Souto L; Ekren R; Blanquart E; Lemaitre L; Feliu V; Joubert MV; Cannons JL; Guillerey C; Avet-Loiseau H; Watts TH; Salomon BL; Joffre O; Grinberg-Bleyer Y; Schwartzberg PL; Lucca LE; Martinet L
    Immunity; 2023 Jul; 56(7):1631-1648.e10. PubMed ID: 37392737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.